Suppr超能文献

迷幻辅助治疗:精神障碍治疗的新方法。

Psychedelic-Assisted Therapy: Emerging Treatments in Mental Health Disorders.

机构信息

Andrew Penn is an associate clinical professor in the University of California, San Francisco School of Nursing. Caroline G. Dorsen is an associate professor and associate dean for advanced practice and clinical partnerships at Rutgers University School of Nursing, Newark, NJ. Stephanie Hope is founder, educator, and coach at Hope Holistic Wellness, Woodbourne, NY. William E. Rosa is a psycho-oncology postdoctoral research fellow in the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, New York City. Andrew Penn receives salary support for his work as coinvestigator on a clinical trial of psilocybin-facilitated therapy for depression (NCT03866174). William E. Rosa is funded by the NIH/NCI Cancer Center Support Grant P30 CA008748 and the NCI award number T32 CA009461. Contact author: Andrew Penn,

出版信息

Am J Nurs. 2021 Jun 1;121(6):34-40. doi: 10.1097/01.NAJ.0000753464.35523.29.

Abstract

Psychedelics are a class of psychoactive substances that were studied extensively between 1943 and 1970 as potential therapies for treating a host of mental health disorders, including addiction. Despite promising early results, U.S. psychedelic research was halted in the early 1970s with the enactment of the Controlled Substances Act. As the field of psychedelic-assisted therapy develops, nurses can decide the role they will play in the continuing clinical and scholarly research of these substances, which may soon be used in controlled settings to treat some of the most widespread mental health disorders. To prepare for this task, this article proposes that nurses * become familiar with the history, relevant language, and scientific findings related to the field of psychedelic research. * learn about existing psychedelic-assisted therapy and research resources. * examine their thoughts, judgments, and opinions about therapeutic psychedelic use. * consider the potential role of nursing in psychedelic-assisted therapies going forward.

摘要

迷幻剂是一类精神活性物质,在 1943 年至 1970 年间被广泛研究,作为治疗多种心理健康障碍(包括成瘾)的潜在疗法。尽管早期结果很有希望,但随着《管制物质法案》的颁布,美国迷幻剂研究在 20 世纪 70 年代初停止。随着迷幻辅助疗法领域的发展,护士可以决定在这些物质的持续临床和学术研究中扮演的角色,这些物质可能很快将在受控环境中用于治疗一些最普遍的心理健康障碍。为了做好这项任务,本文提出,护士应该:* 熟悉迷幻剂研究领域的历史、相关语言和科学发现。* 了解现有的迷幻辅助疗法和研究资源。* 审视他们对治疗性使用迷幻剂的想法、判断和意见。* 考虑在迷幻辅助疗法中护理的潜在作用。

相似文献

2
The Past and Future of Psychedelic Science: An Introduction to This Issue.迷幻科学的过去和未来:本辑导言。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):93-97. doi: 10.1080/02791072.2019.1606472.
3
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.迷幻药物的治疗潜力:过去、现在和未来。
Neuropsychopharmacology. 2017 Oct;42(11):2105-2113. doi: 10.1038/npp.2017.84. Epub 2017 Apr 26.
5
The Role of the in the Evolution of Psychedelic Medicine.在迷幻药物医学的发展中,的作用。
J Psychoactive Drugs. 2019 Apr-Jun;51(2):98-101. doi: 10.1080/02791072.2019.1589607. Epub 2019 Mar 20.

引用本文的文献

3
Nurses' Perceptions of Psychedelics to Address Mental Health Problems in the United States.美国护士对使用迷幻剂解决心理健康问题的看法。
Psychedelic Med (New Rochelle). 2024 Sep 4;2(3):178-183. doi: 10.1089/psymed.2023.0073. eCollection 2024 Sep.

本文引用的文献

9
An introduction to psychedelic neuroscience.迷幻神经科学导论。
Prog Brain Res. 2018;242:1-23. doi: 10.1016/bs.pbr.2018.09.013. Epub 2018 Nov 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验